Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Total Liabilities (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Total Liabilities data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Total Liabilities rose 3.32% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 3.32%, while the annual FY2025 figure was $1.1 billion, 48.19% up from the prior year.
  • Total Liabilities reached $1.1 billion in Q4 2025 per PAHC's latest filing, roughly flat from $1.1 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.1 billion in Q2 2025 and bottomed at $589.1 million in Q1 2021.
  • Average Total Liabilities over 5 years is $766.6 million, with a median of $693.3 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: increased 0.85% in 2023, then surged 51.72% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $609.7 million in 2021, then increased by 13.75% to $693.5 million in 2022, then grew by 1.22% to $701.9 million in 2023, then soared by 47.98% to $1.0 billion in 2024, then increased by 3.32% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.